Estradiol Lowers Vascular Risk in Post-Menopausal Women

Buy Lab Tests Online

Nelson Vergel

Founder, ExcelMale.com
APRIL 8, 2016

Treatment with oral estradiol is linked with lower subclinical atherosclerosis progression when it is started within 6 years after menopause, according to a study involving 643 healthy postmenopausal women.

Participants were divided according to time since menopause, and randomly assigned to receive either oral 17β-estradiol or placebo. Investigators measured carotid-artery intima–media thickness (CIMT) every 6 months. They also assessed coronary atherosclerosis via CT. Among the results after an average of 5 years of follow-up:

• In those who were less than 6 years past menopause, average CIMT increased by 0.0044 mm per year in the estradiol group, vs 0.0078 mm per year in the those receiving placebo.

• Those who were 10 or more years past menopause had similar CIMT progression regardless of what group they were in.

• CT measures of coronary-artery calcium, total stenosis, and plaque did not differ significantly between those taking drug or placebo in either menopause contingent.

Citation: Hodis H, Mack W, Henderson V, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. [Published online ahead of print March 31, 2016]. N Engl J Med. doi:10.1056/NEJMoa1505241.
 
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
9
Guests online
8
Total visitors
17

Latest posts

bodybuilder test discounted labs
Top